Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
05/2012
05/24/2012US20120128589 Perfluoro Compounds For Use In Imaging
05/24/2012US20120128588 Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
05/24/2012US20120128587 Folate-targeted diagnostics and treatment
05/24/2012US20120128586 Method for treating chronic lymphocytic leukemia
05/24/2012US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level
05/24/2012US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
05/24/2012US20120128583 Dtpa derivative, metal complex, mr and ct contrast agent and method for manufacturing same
05/24/2012US20120128582 Methods and compositions of [32p]-labeled adenine nucleotides for the treatment of atherosclerosis, vascular arterial diseases and coronary artery diseases
05/24/2012US20120128581 Sincalide Formulations
05/24/2012US20120128580 Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status
05/23/2012EP2455946A1 Method and plant for filling a bottle with a radioactive fluid-base mixture
05/23/2012EP2455105A2 Bombesin analogues
05/23/2012EP2453927A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
05/23/2012EP2453923A2 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier
05/23/2012CN1826138B Rg1 antibodies and uses thereof
05/23/2012CN102470184A 采用放射性种子的肿瘤治疗 Cancer treatment using radioactive seeds
05/23/2012CN102470181A ε-聚赖氨酸缀合物及其用途 ε- polylysine conjugates and their use
05/23/2012CN102464688A 胸苷环磷酸酯化合物及其抗肿瘤用途 Thymidine cyclic phosphate compounds and their use of anti-tumor
05/23/2012CN102462848A Preparation method and application of 11C-tumour metabolism developer
05/23/2012CN101970017B Imaging the central nervous system
05/23/2012CN101257929B Gentisic acid for stabilisig 123-i radiopharmaceuticals
05/22/2012US8183226 Myocardial perfusion imaging method
05/22/2012US8182789 Intermediate compound of technetium nitride complex for radiodiagnostic imaging
05/22/2012US8182788 Autoclaving of the 18F-FDG-solution is performed at a temperature of 134EC; temperature is optimal considering stability and half-life of the 18F radio-isotope; improved physical/chemical characteristics, i.e. radiochemical stability; use in cardiology and neurology; ability to detect cancerous tissue
05/22/2012CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells
05/22/2012CA2439448C Polymer precursors of radiolabeled compounds, and methods of making and using the same
05/18/2012WO2012065161A2 Antibodies to tumor endothelial marker 8
05/18/2012WO2012063028A1 Conjugates and their uses in molecular imaging
05/18/2012WO2012062949A1 Liposomes with antibodies against markers of the cerebral peri-infarct zone
05/18/2012WO2012062319A1 Radiolabelled phenylimidazole-based ligands
05/18/2012CA2817385A1 Radiolabelled phenylimidazole-based ligands
05/17/2012US20120123189 Oncology therapies employing radioactive seeds
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121509 Vital fluorochrome conjugates and methods of use
05/17/2012US20120121508 Radiolabeled cgrp antagonists
05/17/2012US20120121507 Peptide ligands for clusterin and uses thereof
05/17/2012US20120121506 Targeting of Bone Marrow Neovasculature
05/17/2012US20120121505 Therapeutic compositions and methods
05/17/2012US20120121504 B cell surface reactive antibodies
05/17/2012US20120121503 Inhibition Of CD69 For Treatment Of Inflammatory Conditions
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/17/2012US20120121501 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
05/16/2012EP2452695A2 Positron emission tomography imaging method
05/16/2012EP2451488A2 Multimodal visible polymer embolization material
05/16/2012EP1904460B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
05/16/2012CN102458482A Imaging tumor perfusion, oxidative metabolism using dynamic ace pet in patients with head and neck cancer during radiotherapy
05/16/2012CN102458396A Stabilization of radiopharmaceutical compositions using ascorbic acid
05/16/2012CN102452873A Compound containing carbon or oxygen isotope and preparation method thereof and application thereof and composition thereof
05/16/2012CN102451476A Radionuclide-doped magnetic nano crystal with biocompatibility, and preparation method of radionuclide-doped magnetic nano crystal
05/16/2012CN101985456B Bone-seeking 99mTc-IPrDP coordination compound as well as preparation method and application thereof
05/15/2012US8178076 Diagnosis and assessment of skeletal related disease using calcium 41
05/10/2012WO2012060707A1 Microsphere comprising a lanthanide metal complex
05/10/2012WO2012027527A3 Microreactor and method for preparing a radiolabeled complex or a biomolecule conjugate
05/10/2012WO2012021045A3 Sentinel lymph node marker capable of multi-mode imaging
05/10/2012US20120114662 Human monoclonal antibodies against bacillus anthracis protective antigen
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114557 Methods for Collagen Imaging
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120114555 Method for treating immune disorders
05/10/2012US20120114554 Engineered Aerosol Particles, And Associated Methods
05/10/2012CA2816797A1 Microsphere comprising a lanthanide metal complex
05/09/2012EP2450354A1 Labeling compound for pet
05/09/2012EP2448966A1 Immuno-conjugates and methods for producing them
05/09/2012EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy
05/09/2012EP1368064B1 Synthesis of tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
05/09/2012CN102448933A Indole derivatives
05/09/2012CN102448500A Conjugation methods
05/09/2012CN102446570A 68 Ga generator
05/09/2012CN102442996A Polyamine micromolecular developer, production method and application thereof
05/08/2012US8173102 Tame based chelators and uses thereof
05/03/2012WO2012057312A1 Tau imaging probe
05/03/2012WO2012055992A2 Stabilisation of radiopharmaceutical precursors
05/03/2012WO2012054998A1 Method for labelling with radionuclides somatostatin analogues associated with diseases with physiopathogenesis involving somatostatin receptors, reagent for in vivo and/or in vitro diagnosis on the basis of somatostatin analogues linked to radionuclides, method for diagnosing in vitro or in vivo diseases with physiopathogenesis involving somatostatin receptors, using the thus obtained reagent, and kit containing said reagent for diagnosing diseases with physiopathogenesis involving somatostatin
05/03/2012WO2012054997A1 Method for labelling with radionuclides murine or human, monoclonal or polyclonal anti-tumour necrosis factor antibodies associated with diseases with physiopathogenesis involving tumor necrosis factor; reagent for in vivo and/or in vitro diagnosis on the basis of murine or human, monoclonal or polyclonal anti-tumor necrosis factor antibodies linked to radionuclides; methods for diagnosing in vitro and/or in vivo diseases with physiopathogenesis involving the tumour necrosis factor, using the thus obtained reagent, and kit containing said reagent for diagnosing diseases with physiopathogenesis involving the tumour necrosis factor
05/03/2012US20120110682 Animal Model for Toxicology and Dose Prediction
05/03/2012US20120107249 Diagnostic Imaging Contrast Agents with Extended Blood Retention
05/03/2012US20120107240 Probes and methods of melanoma imaging
05/03/2012US20120107239 Precursor of Molecular Probe for Pancreatic Islet Imaging and Use of the Same
05/03/2012US20120107238 Compound containing a carbon or an oxygen isotope, preparation and use thereof, and composition comprising thereof
05/03/2012US20120107237 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120107234 Pan-HER Antibody Composition
05/03/2012US20120107233 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
05/03/2012US20120107232 Kit for preparing a radiolabeled liposome and a method using the same
05/03/2012US20120107231 Metalloproteinase binding proteins
05/03/2012US20120107230 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide Analogs
05/03/2012US20120107229 Novel nano-probes for molecular imaging and targeted therapy of diseases
05/03/2012CA2815960A1 Tau imaging probe
05/02/2012EP2125038B1 Radioactive pet agents for imaging ccr5 in vivo
05/02/2012EP1691847B1 Tame based chelators and uses thereof
05/02/2012CN102438660A Imaging agents for detecting neurological disorders
05/02/2012CN102438656A Pretargeting kit, method and agents used therein
05/02/2012CN102438646A Treatment of metastatic tumors
05/02/2012CN102432531A Phenylmethanesulfonamide derivative and its preparation method
05/02/2012CN102432529A Styryl pyridine disulfide dinitrogen derivative and preparation method thereof
05/02/2012CN102430134A Application of radiolabeled irradiation anthranone or naphtho dianthrone compounds to preparation of antitubercular medicine
05/02/2012CN102430133A Radioactive medicine synthesis module capable of being repeatedly used in same day
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/01/2012US8168586 Cancer targets and uses thereof
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 243